Sunitinib-induced thrombotic microangiopathy: a case report

preprint OA: closed
View at publisher

Abstract

Sunitinib-induced thrombotic microangiopathy (TMA) is a secondary TMA caused by Sunitinib.Despite the extensive use of the drug ,little is known about this complication of Sunitinib. In this study, we reported a 63 years old male with Sunitinib induced TMA treated for metastatic renal cell carcinoma.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00